ASX:SHGHealth Care Equipment & ServicesHealth Care Technology

SINGULAR HEALTH GROUP ORD

$0.205
$0.020 (8.89%)
Day Range
$0.205 - $0.225
52 Week Range
$0.180 - $0.420
Volume
148.62K
Avg Volume (10D)
362.98K
Market Cap
$64.72M
Price Chart
Market Statistics
Open$0.225
Previous Close$0.225
Day High$0.225
Day Low$0.205
52 Week High$0.420
52 Week Low$0.180
Valuation
Market Cap64.72M
Shares Outstanding315.69M
Price to Book5.51
Trading Activity
Volume148.62K
Value Traded32.73K
Bid$0.205 × 57,542
Ask$0.225 × 100,000
Performance
1 Day-8.89%
5 Day-12.77%
13 Week-21.15%
52 Week-19.61%
YTD-19.61%
Technical Indicators
RSI (14)36.66
50-Day SMA$0.243
200-Day SMA$0.287
Latest News
Singular Health secures PNS deal and  finalises $8m placement for US expansion
Biotechnology

Singular Health secures PNS deal and finalises $8m placement for US expansion

Singular Health Group (ASX: SHG) has signed a binding $2 million contract with US firm Provider Network Solutions (PNS) for further adoption of Singular’s 3DICOM medical imaging platform. Florida-headquartered PNS is a leading managed healthcare service organisation (MSO) which looks after the healthcare of more than 3.7 million members. The contract allows for the initial […]

1 min read
Colin Hay
Colin Hay
Singular Health secures $850,000 strategic investment from CG1 Ventures
Technology

Singular Health secures $850,000 strategic investment from CG1 Ventures

Perth-based medical technology company Singular Health (ASX: SHG) has received commitments to raise a maximum $850,000 through a share placement with master distributor and US partner CG1 Ventures. CG1 has committed to a strategic investment at $0.055 per share, which is a 41% premium to Singular’s last closing price of $0.039. It is also the […]

2 min read
Imelda Cotton
Imelda Cotton
Osteopore and Singular Health collaborate on AI-powered cranial implant design process
Biotechnology

Osteopore and Singular Health collaborate on AI-powered cranial implant design process

Bone healing biotech Osteopore (ASX: OSX) has inked a deal with Singular Health Group (ASX: SHG) for a comparative study between Osteopore’s existing cranial implant design process and a new artificial intelligence design engine in a clinical environment. The study seeks to validate the results of the new AI engine, using Osteopore’s data set of […]

1 min read
Imelda Cotton
Imelda Cotton
Diagnostic imaging: which stock will become the next Pro Medicus?
Hot Topics

Diagnostic imaging: which stock will become the next Pro Medicus?

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient. The underlying tech hasn’t really moved on since 1895, when […]

6 min read
Tim Boreham
Tim Boreham